{"product_id":"cracking-the-code-isbn-9781119963189","title":"Cracking the Code","description":"\u003cb\u003eEverything you need to know about the most important trend in the history of the world\u003c\/b\u003e\u003cbr\u003e \u003cbr\u003e   \u003cp\u003eWithin most people's lifetimes, the developments in the biotechnology sector will allow us to live increasingly long and healthy lives, as well as provide us with technological innovations that will transform the way we live. But these innovations offer more than just hope for a better life, but hope for better returns too. Financial returns of incredible magnitude await savvy investors and businesspeople who can see the massive changes on the horizon. This book details these fast-moving trends and innovations and offers extensive advice on how to profit from them in business and investing.\u003c\/p\u003e \u003cp\u003eAcknowledgements ix\u003c\/p\u003e \u003cp\u003eIntroduction xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter One Transformational Technologies 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFuturists and Scientists Look into the Future 1\u003c\/p\u003e \u003cp\u003eThe Convergence of Technology and Biology 13\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Two The Evolution of Medicine and the Emergence of Biopharma 23\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFrom Atoms to Cells to Living Organisms 24\u003c\/p\u003e \u003cp\u003eThe History of the Pharmaceutical Industry 36\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Three The Drug Industry – Reinventing the Model 55\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBig Pharma, Biopharma 59\u003c\/p\u003e \u003cp\u003eDrug Patents 73\u003c\/p\u003e \u003cp\u003eThe Path to Riches: FDA Approval 79\u003c\/p\u003e \u003cp\u003eIn Summary 84\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Four Curing Disease – Promising Prospects in the Main Therapeutic Areas 87\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCancer – Step by Step, Being Beaten 89\u003c\/p\u003e \u003cp\u003eInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector 107\u003c\/p\u003e \u003cp\u003eObesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease 118\u003c\/p\u003e \u003cp\u003eThe Heart of the Matter – Biggest Killer on the Prowl 128\u003c\/p\u003e \u003cp\u003eFading into the Night – Neurodegeneration, Rheumatology and Multiple Sclerosis 132\u003c\/p\u003e \u003cp\u003eRespiratory Disease – New Drugs: A Breath of Fresh Air 143\u003c\/p\u003e \u003cp\u003eRare Diseases and Rare Profits 146\u003c\/p\u003e \u003cp\u003eDrugs for Pain and for the Central Nervous System 150\u003c\/p\u003e \u003cp\u003eThe Best of the Rest – Ophthalmology, Dermatology, Gastrointestinal and Bone Disease 153\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Five Turning Back the Clock – Stem Cells, Genomics, Gene Therapy and Regeneration 157\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eStem Cells 166\u003c\/p\u003e \u003cp\u003eGene Therapy and Nano Medicine 170\u003c\/p\u003e \u003cp\u003eOrgan Growth in and out of the Body 178\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Six Demographic Changes 181\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe Working Age Labour Pool in the World is Shrinking 191\u003c\/p\u003e \u003cp\u003eCan Immigration Solve the Labour Shortage in the Developed World? 193\u003c\/p\u003e \u003cp\u003eThe Social Impact of an Ageing Population 195\u003c\/p\u003e \u003cp\u003eThe United States is the Best Positioned Developed Country 196\u003c\/p\u003e \u003cp\u003eSupport Ratios Have Been Plummeting 197\u003c\/p\u003e \u003cp\u003eChina’s Grey Future 198\u003c\/p\u003e \u003cp\u003eWhat Can Governments Do To Avoid Their Country Becoming a Nursing Home? 200\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Seven Bioscience’s Disruptive Influences 205\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eInsurance and Healthcare 206\u003c\/p\u003e \u003cp\u003eReal Estate 210\u003c\/p\u003e \u003cp\u003ePolitics 211\u003c\/p\u003e \u003cp\u003eGeopolitics 211\u003c\/p\u003e \u003cp\u003eRetail Goods and Services 212\u003c\/p\u003e \u003cp\u003eThe Food Industry 213\u003c\/p\u003e \u003cp\u003eThe Investment Industry 214\u003c\/p\u003e \u003cp\u003eThe Law 215\u003c\/p\u003e \u003cp\u003eShortage of Young People in Developed Nations 217\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Eight Robotics and Nanotechnology 219\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eRobotics 219\u003c\/p\u003e \u003cp\u003eSurgical Procedures\/Surgical Assistance 220\u003c\/p\u003e \u003cp\u003eMedical Monitor\/Nurse 223\u003c\/p\u003e \u003cp\u003eHousemaid\/Domestic Assistance 228\u003c\/p\u003e \u003cp\u003eCompanion\/Pet 229\u003c\/p\u003e \u003cp\u003eNanotechnology 232\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Nine Lifestyle Maintenance 235\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIt’s a Fact: Obesity Shortens Your Life 235\u003c\/p\u003e \u003cp\u003eExtending Life Expectancy 237\u003c\/p\u003e \u003cp\u003eCommon Traits of People who Live the Longest 239\u003c\/p\u003e \u003cp\u003eA “Cure” to Ageing 240\u003c\/p\u003e \u003cp\u003eTelomeres – Our Biological Clock 244\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter Ten Investment in Biopharma – Chasing Those Money Fountains 247\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eConservative Portfolio 279\u003c\/p\u003e \u003cp\u003eBalanced Portfolio 280\u003c\/p\u003e \u003cp\u003eSpeculative Portfolio 281\u003c\/p\u003e \u003cp\u003eCompany Overviews 282\u003c\/p\u003e \u003cp\u003eSummary 305\u003c\/p\u003e \u003cp\u003eGlossary 315\u003c\/p\u003e \u003cp\u003eAppendix – Key Financial Charts of Big Pharma 325\u003c\/p\u003e \u003cp\u003eReferences 327\u003c\/p\u003e \u003cp\u003eBibliography 329\u003c\/p\u003e \u003cp\u003eIndex 331\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJIM MELLON \u003c\/b\u003eis an investor with interests in several industries. He is founder of a listed fund management company, Charlemagne Capital, and an Asian mining group, Regent Pacific. In addition, Jim is a director of Manx Financial Group – an Isle of Man based bank, and a controlling shareholder of Speymill – a property business, and Webis Holdings. He is a co-founder of Uramin and West African Minerals Resources, both mining groups. The Burnbrae Group, his private company, is a substantial landlord in Germany and in the Isle of Man, and he also owns the hotel chain Sleepwell Hotels. Jim spends most of his time working on start-up ideas and on investing. Jim lives in the Isle of Man, Brussels and Ibiza. He is an honorary fellow of Oriel College, Oxford.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAL CHALABI\u003c\/b\u003e is an entrepreneur with a diverse professional background who started his career as a systems engineer in Canada. Following this, he worked as a management consultant advising corporations across a number of industries, and more recently as the CFO for a real estate investment company. He currently runs CASP-R, a firm he co-founded in 2008 to provide independent real estate research and advisory services to investors and corporate occupiers across the Asia-Pacific region. He lives in Hong Kong with his partner Fiona and two young children.  \u003c\/p\u003e\u003cp\u003e\u003cb\u003eWAKE UP TO THE MOST IMPORTANT TREND IN THE HISTORY OF THE WORLD\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThere is a new gold rush on. The single biggest trend to affect mankind is here, and there are fortunes to be made. \u003c\/p\u003e\u003cp\u003eThe next phase in the world’s development will not be dominated by the rise of China or India, or by green technologies, important though they are. Rather the world as we know it is about to be transformed by breakthrough achievements in human life extension and improvement. Entire industries are soon to be disrupted by developments in Biotechnology. And there are unparalleled opportunities for early investors to profit. \u003c\/p\u003e\u003cp\u003eThis amazing acceleration in technological development is coming under the radar for many, but will soon prove to be more important to the human race than the internet, iPads, smartphones and all the other material goods we regard as technology. The fusion of technology and medicine will enable us to live longer and healthier lives with a considerably superior quality of life. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eLEARN, DIGEST, INFORM AND INVEST\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003ci\u003eCRACKING THE CODE \u003c\/i\u003eis the first book to explore with full clarity the implications of an industry that will define the 21\u003csup\u003est\u003c\/sup\u003e century and to outline the huge returns to be had for those who invest in the companies behind these products and the changing demographic that this technology will bring about.  \u003c\/p\u003e\u003cp\u003eLeading investment experts Jim Mellon and Al Chalabi have spent a year immersed in the life sciences industry, researching and interviewing over 100 companies. Writing not as scientists but as investors, they strip away the technical jargon and demystify the information to help you to under­stand the science and clearly identify the key industry participants and investment opportunities.  \u003c\/p\u003e\u003cp\u003eThe first authors to forecast an economic crisis, as early as 2005 in their book \u003ci\u003eWake Up!\u003c\/i\u003e, show you how the biotech industry’s biggest successes will dwarf the current colossi of the stock markets. May you live long and prosper from it.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47988999880933,"sku":"NP9781119963189","price":30.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119963189.jpg?v=1761782377","url":"https:\/\/k12savings.com\/products\/cracking-the-code-isbn-9781119963189","provider":"K12savings","version":"1.0","type":"link"}